{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:12:22Z","timestamp":1790381542516,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03407-2","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:02:09Z","timestamp":1764169329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of DPP-1 inhibitors in bronchiectasis: a GRADE-assessed meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"26","author":[{"given":"Ahmed","family":"Emara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer","family":"Awashra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ellebedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar F.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Diaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Emara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalhakim","family":"Shubietah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Muhsen Z.","family":"Abdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"10150","key":"3407_CR1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0140-6736(18)31554-X","volume":"392","author":"AB Chang","year":"2018","unstructured":"Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Lancet. 2018;392(10150):866\u201379.","journal-title":"Lancet"},{"issue":"1","key":"3407_CR2","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1186\/s12889-024-19956-y","volume":"24","author":"L Wang","year":"2024","unstructured":"Wang L, Wang J, Zhao G, Li J. Prevalence of bronchiectasis in adults: a meta-analysis. BMC Public Health. 2024;24(1):2675.","journal-title":"BMC Public Health"},{"key":"3407_CR3","doi-asserted-by":"crossref","unstructured":"Nigro M, Laska IF, Traversi L, Simonetta E, Polverino E. Epidemiology of bronchiectasis. Eur Respir Rev. 2024;33(174):240091.","DOI":"10.1183\/16000617.0091-2024"},{"key":"3407_CR4","doi-asserted-by":"crossref","unstructured":"Chalmers JD, Goeminne PC, Ringshausen FC. EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference. Eur Respir Rev. 2024;33(173):240124.","DOI":"10.1183\/16000617.0124-2024"},{"issue":"1","key":"3407_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.chest.2024.01.045","volume":"166","author":"R Cordeiro","year":"2024","unstructured":"Cordeiro R, Choi H, Haworth CS, Chalmers JD. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: updated systematic review and Meta-Analysis. Chest. 2024;166(1):61\u201380.","journal-title":"Chest"},{"key":"3407_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12879-015-0872-5","volume":"15","author":"L-C Fan","year":"2015","unstructured":"Fan L-C, Lu H-W, Wei P, Ji X-B, Liang S, Xu J-F. Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials. BMC Infect Dis. 2015;15:160.","journal-title":"BMC Infect Dis"},{"key":"3407_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1183\/16000617.0179-2024","volume":"34","author":"JD Chalmers","year":"2025","unstructured":"Chalmers JD, Metersky M, Aliberti S, Morgan L, Fucile S, Lauterio M, et al. Neutrophilic inflammation in bronchiectasis. Eur Respir Rev. 2025;34:176.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"3407_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12931-023-02444-z","volume":"24","author":"D Cipolla","year":"2023","unstructured":"Cipolla D, Zhang J, Korkmaz B, Chalmers JD, Basso J, Lasala D, et al. Dipeptidyl peptidase-1 Inhibition with brensocatib reduces the activity of all major neutrophil Serine proteases in patients with bronchiectasis: results from the WILLOW trial. Respir Res. 2023;24(1):133.","journal-title":"Respir Res"},{"issue":"22","key":"3407_CR9","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","volume":"383","author":"JD Chalmers","year":"2020","unstructured":"Chalmers JD, Haworth CS, Metersky ML, Loebinger MR, Blasi F, Sibila O, et al. Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. N Engl J Med. 2020;383(22):2127\u201337.","journal-title":"N Engl J Med"},{"issue":"5","key":"3407_CR10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S2213-2600(25)00019-0","volume":"13","author":"N-S Zhong","year":"2025","unstructured":"Zhong N-S, Qiu R, Cao J, Huang Y-M, Zhou H, Xu X-X, et al. Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Respir Med. 2025;13(5):414\u201324.","journal-title":"Lancet Respir Med"},{"key":"3407_CR11","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71.","DOI":"10.1136\/bmj.n71"},{"key":"3407_CR12","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5 (updated August 2024). www.training.cochrane.org\/handbook: Cochrane; 2024."},{"key":"3407_CR13","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"issue":"7650","key":"3407_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"11","key":"3407_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"key":"3407_CR16","doi-asserted-by":"crossref","unstructured":"Chalmers JD, Shteinberg M, Mall MA, O\u2019Donnell AE, Watz H, Gupta A et al. Cathepsin C (dipeptidyl peptidase 1) Inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study. Eur Respir J. 2025;65(1):2401551.","DOI":"10.1183\/13993003.01551-2024"},{"issue":"16","key":"3407_CR17","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","volume":"392","author":"JD Chalmers","year":"2025","unstructured":"Chalmers JD, Burgel P-R, Daley CL, De Soyza A, Haworth CS, Mauger D, et al. Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. N Engl J Med. 2025;392(16):1569\u201381.","journal-title":"N Engl J Med"},{"key":"3407_CR18","doi-asserted-by":"crossref","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629.","DOI":"10.1183\/13993003.00629-2017"},{"issue":"Suppl 1","key":"3407_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, et al. British thoracic society guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1\u201369.","journal-title":"Thorax"},{"key":"3407_CR20","doi-asserted-by":"crossref","unstructured":"Choi H, McShane PJ, Aliberti S, Chalmers JD. Bronchiectasis management in adults: state of the Art and future directions. Eur Respir J. 2024;63(6):2400518.","DOI":"10.1183\/13993003.00518-2024"},{"key":"3407_CR21","doi-asserted-by":"crossref","unstructured":"Chalmers JD, Gupta A, Chotirmall SH, Armstrong A, Eickholz P, Hasegawa N et al. A phase 2 randomised study to Establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: airleaf. ERJ Open Res. 2023;9(3):00633-2022.","DOI":"10.1183\/23120541.00633-2022"},{"issue":"1","key":"3407_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12931-017-0691-x","volume":"18","author":"A Gramegna","year":"2017","unstructured":"Gramegna A, Amati F, Terranova L, Sotgiu G, Tarsia P, Miglietta D, et al. Neutrophil elastase in bronchiectasis. Respir Res. 2017;18(1):211.","journal-title":"Respir Res"},{"issue":"10","key":"3407_CR23","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","volume":"195","author":"JD Chalmers","year":"2017","unstructured":"Chalmers JD, Moffitt KL, Suarez-Cuartin G, Sibila O, Finch S, Furrie E, et al. Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis. Am J Respir Crit Care Med. 2017;195(10):1384\u201393.","journal-title":"Am J Respir Crit Care Med"},{"key":"3407_CR24","doi-asserted-by":"publisher","first-page":"108243","DOI":"10.1016\/j.rmed.2025.108243","volume":"246","author":"J Bajpai","year":"2025","unstructured":"Bajpai J, Kant S, Matera MG, Cazzola M. Targeting neutrophilic inflammation in obstructive airway disease - A narrative review of brensocatib therapy. Respir Med. 2025;246:108243.","journal-title":"Respir Med"},{"key":"3407_CR25","first-page":"297686752413008","volume":"19","author":"MA Alam","year":"2024","unstructured":"Alam MA, Mangapuram P, Fredrick FC, Singh B, Singla A, Kumar A, et al. Bronchiectasis-COPD overlap syndrome: A comprehensive review of its pathophysiology and potential cardiovascular implications. Ther Adv Pulm Crit Care Med. 2024;19:29768675241300810.","journal-title":"Ther Adv Pulm Crit Care Med"},{"issue":"3","key":"3407_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1172\/JCI0213462","volume":"109","author":"AM Adkison","year":"2002","unstructured":"Adkison AM, Raptis SZ, Kelley DG, Pham CTN. Dipeptidyl peptidase I activates neutrophil-derived Serine proteases and regulates the development of acute experimental arthritis. J Clin Invest. 2002;109(3):363\u201371.","journal-title":"J Clin Invest"},{"key":"3407_CR27","doi-asserted-by":"publisher","first-page":"1239151","DOI":"10.3389\/fimmu.2023.1239151","volume":"14","author":"JD Chalmers","year":"2023","unstructured":"Chalmers JD, Kettritz R, Korkmaz B. Dipeptidyl peptidase 1 Inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease. Front Immunol. 2023;14:1239151.","journal-title":"Front Immunol"},{"issue":"12","key":"3407_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","volume":"38","author":"A Ray","year":"2017","unstructured":"Ray A, Kolls JK. Neutrophilic inflammation in asthma and association with disease severity. Trends Immunol. 2017;38(12):942\u201354.","journal-title":"Trends Immunol"},{"key":"3407_CR29","doi-asserted-by":"publisher","first-page":"8840594","DOI":"10.1155\/2023\/8840594","volume":"2023","author":"BK Shah","year":"2023","unstructured":"Shah BK, Singh B, Wang Y, Xie S, Wang C. Mucus hypersecretion in chronic obstructive pulmonary disease and its treatment. Mediators Inflamm. 2023;2023:8840594.","journal-title":"Mediators Inflamm"},{"issue":"6","key":"3407_CR30","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.resinv.2024.09.004","volume":"62","author":"N Nakagawa","year":"2024","unstructured":"Nakagawa N, Ito M, Asakura T, Horita N, Obase Y, Mukae H. Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Respir Investig. 2024;62(6):1079\u201387.","journal-title":"Respir Investig"},{"issue":"10","key":"3407_CR31","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s40262-022-01147-w","volume":"61","author":"JD Chalmers","year":"2022","unstructured":"Chalmers JD, Usansky H, Rubino CM, Teper A, Fernandez C, Zou J, et al. Pharmacokinetic\/Pharmacodynamic evaluation of the dipeptidyl peptidase 1 inhibitor brensocatib for Non-cystic fibrosis bronchiectasis. Clin Pharmacokinet. 2022;61(10):1457\u201369.","journal-title":"Clin Pharmacokinet"},{"key":"3407_CR32","doi-asserted-by":"crossref","unstructured":"Johnson ED, Long MB, Perea L, Shih VH, Fernandez C, Teper A et al. Broad Immunomodulatory effects of the Dipeptidyl-peptidase-1 inhibitor brensocatib in bronchiectasis: data from the phase 2, Double-Blind, Placebo-controlled WILLOW trial. Am J Respir Crit Care Med. 2025;211(5):770-778.","DOI":"10.1164\/rccm.202408-1545OC"},{"key":"3407_CR33","doi-asserted-by":"crossref","unstructured":"Chalmers JD, Metersky ML, Feliciano J, Fernandez C, Teper A, Maes A et al. Benefit-risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis. ERJ Open Res. 2023;9(3):00695-2022.","DOI":"10.1183\/23120541.00695-2022"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03407-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03407-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03407-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:02:11Z","timestamp":1764169331000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03407-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3407"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03407-2","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}